Healthcare -
Biotechnology - NASDAQ - US
$ 2.475
-8.67 %
$ 176 M
Market Cap
-1.63
P/E
CCCC - STOCK-BASED COMPENSATION
Stock-based Compensation CCCC - C4 Therapeutics, Inc.
27.2 M
LAST VALUE
12.52%
2 YEAR CAGR
115.79%
5 YEAR CAGR
0.00%
10 YEAR CAGR